Exogenous protein-expressing microorganism and use thereof
Summary
The European Patent Office published patent EP3858995A2 granted to Medytox Inc. on April 1, 2026, covering an exogenous protein-expressing microorganism and its applications. The patent specifies designated states across EU member nations and multiple IPC classifications spanning therapeutic, nutritional, and pharmaceutical uses.
What changed
The European Patent Office granted Medytox Inc. patent EP3858995A2 for an exogenous protein-expressing microorganism and its applications. The patent covers therapeutic uses including gastrointestinal treatments (A61P1/00), anti-inflammatory applications (A61P29/00), pharmaceutical compositions (A61K35/747, A61K45/06), and nutritional applications (A23L33/135). The patent is designated across 31 European states including Germany, France, Italy, Spain, and the United Kingdom.
For biotechnology companies, pharmaceutical developers, and food manufacturers working with protein-expressing microorganisms, this patent establishes intellectual property rights that may affect research directions and product development strategies. Parties developing similar technologies or products should conduct freedom-to-operate analyses and consider licensing arrangements with Medytox Inc.
What to do next
- Review patent claims for freedom-to-operate analysis
- Monitor for licensing opportunities with Medytox Inc.
- Assess product development pipeline for potential infringement
Archived snapshot
Apr 8, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
EXOGENOUS PROTEIN-EXPRESSING MICROORGANISM AND USE THEREOF
Publication EP3858995A2 Kind: A2 Apr 01, 2026
Applicants
Medytox Inc.
Inventors
SONG, Ji Yoon, NOH, Hyeon Jin, JUNG, Yi Reh, KIM, Yeung Hyen, CHO, Seung Kee
IPC Classifications
C12N 15/74 20060101AFI20211214BHEP C12N 15/67 20060101ALI20211214BHEP C07K 14/575 20060101ALI20211214BHEP A23L 33/135 20160101ALI20211214BHEP A61K 35/747 20150101ALI20211214BHEP A61K 45/06 20060101ALI20211214BHEP A61P 1/00 20060101ALI20211214BHEP A61P 29/00 20060101ALI20211214BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.